0002127885-26-000001.txt : 20260603 0002127885-26-000001.hdr.sgml : 20260603 20260603170044 ACCESSION NUMBER: 0002127885-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260603 DATE AS OF CHANGE: 20260603 EFFECTIVENESS DATE: 20260603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Goldenrod Therapeutics, Inc. CENTRAL INDEX KEY: 0002127885 ORGANIZATION NAME: EIN: 992482814 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-586108 FILM NUMBER: 261061797 BUSINESS ADDRESS: STREET 1: 3900 ESSEX LANE, SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: 713-966-5844 MAIL ADDRESS: STREET 1: 3900 ESSEX LANE, SUITE 575 CITY: HOUSTON STATE: TX ZIP: 77027 D 1 primary_doc.xml X0708 D LIVE 0002127885 Goldenrod Therapeutics, Inc. 3900 ESSEX LANE, SUITE 575 HOUSTON TX TEXAS 77027 713-966-5844 TEXAS None None Corporation true 2023 Leo Linbeck III 3900 Essex Lane Suite 575 Houston TX TEXAS 77027 Director Atul Varadhachary 3900 Essex Lane Suite 575 Houston TX TEXAS 77027 Executive Officer Director Thomas Brenninkmeijer 3900 Essex Lane Suite 575 Houston TX TEXAS 77027 Director Dev Chatterjee 3900 Essex Lane Suite 575 Houston TX TEXAS 77027 Executive Officer Leo Linbeck IV 3900 Essex Lane Suite 575 Houston TX TEXAS 77027 Executive Officer Mark Worscheh 3900 Essex Lane Suite 575 Houston TX TEXAS 77027 Executive Officer Director Biotechnology Decline to Disclose 06b false 2026-05-26 false true false 100000 6510000 3245355 3264645 false 2 0 0 0 false Goldenrod Therapeutics, Inc. Jordan Lee Jordan Lee POA from Atul Varadhachary 2026-06-03